BAM7 is a direct and selective activator of proapoptoticBAXwith anIC₅₀of 3.3 μM.

BAM7 is selective for the BH3-binding site on BAX. BAM7 activates BAX and BAX-dependent cell death. Whereas treatment with BAX or BAM7 alone has no effect on the liposomes, the combination of BAM7 and BAX yields dose-responsive liposomal release of entrapped fluorophore. BAM7 dose- and time-responsively impairs the viability ofBak^-/-MEFs that exclusively express BAX but has no effect onBak^-/-MEFs that contain BAK but lack BAX. In contrast, standard proapoptotic stimuli such as serum withdrawal, Staurosporine and Etoposide induces an equivalent apoptotic response inBax^-/-andBak^-/-MEFs. As further evidence of BAM7 specificity of action, (i) BAM7 does not affect the viability ofBax^-/-Bak^-/-MEFs; (ii) ANA-BAM16, which does not bind or activate BAX, has no effect onBak^-/-MEFs; and (iii) BAM7 selectively induces cell death ofBax^-/-Bak^-/-MEFs reconstituted with wild-type BAX but not BAXK21E , which bears the mutation that abrogates BAM7 binding^[1].

405.47

Solid

C₂₁H₁₉N₅O₂S

331244-89-4

Room temperature in continental US; may vary elsewhere.

DMSO : 5 mg/mL(12.33 mM;Need ultrasonic)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

• 1.

  请依序添加每种溶剂： 10% DMSO    90%corn oil

  Solubility: ≥ 0.5 mg/mL (1.23 mM); Clear solution

  此方案可获得 ≥ 0.5 mg/mL (1.23 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

  以 1 mL 工作液为例，取 100 μL 5.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。